Bioamber Inc. (BIOA): Kenneth W. Wall , director of Bioamber Inc. purchased 13,227 shares on May 9, 2016. The Insider buying transaction was reported by the company on May 11, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.11 per share for a total value of $41,135.97 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 9, 2016, Michael A. Hartmann (Executive Vice President) purchased 3,000 shares at $3.42 per share price.On Dec 4, 2015, Jean-francois Huc (President and CEO) sold 27,278 shares at $8.11 per share price.Also, On Sep 1, 2015, Andrew P. Ashworth (CFO) purchased 700 shares at $6.01 per share price.On Aug 13, 2015, Kenneth W. Wall (director) purchased 10,000 shares at $6.05 per share price.
Bioamber Inc: On Tuesday, May 10, 2016 heightened volatility was witnessed in Bioamber Inc which led to swings in the share price. The shares opened for trading at $3.3428 and hit $3.41 on the upside , eventually ending the session at $3.39, with a gain of 2.42% or 0.08 points. The heightened volatility saw the trading volume jump to 18,870 shares. The 52-week high of the share price is $9.09 and the company has a market cap of $98 M . The 52-week low of the share price is at $2.865.
BioAmber Inc. (BioAmber) is an industrial biotechnology company which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals which are used in a wide range of everyday products including plastics resins food additives and personal care products. The Company is developing three distinct technologies such as the production of succinic acid through fermentation; the conversion of succinic acid into 14 BDO THF and GBL by catalyst assisted hydrogenation reaction and the production of adipic acid and other C6 chemical intermediates through fermentation and purification with or without catalytic conversion. BioAmber manufactures and sells bio-succinic acid to the customers in a range of chemical markets. It produces bio-succinic acid in a facility using a 350000 liter fermenter in Pomacle France.